Schonfeld Strategic Advisors LLC
Position in XERS — Xeris Biopharma Holdings, Inc.
CIK 1665241
NEW YORK, NY
Position in XERS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,719,299
-$123,276 QoQ
Shares Held
296,431
+26.3% QoQ
Ownership
0.172%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
11 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Schonfeld Strategic Advisors LLC holds $50,240,980 across 18 Drug Manufacturers - Specialty & Generic names. XERS ranks #8 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ANIP |
Ani Pharmaceuticals Inc
|
185,629 | $14,274,870 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,337,693 | $12,734,837 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
56,615 | $7,458,460 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
4,290 | $2,543,884 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
48,765 | $2,520,662 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
43,599 | $2,099,291 | |
| 7 | ZTS |
Zoetis Inc.
|
16,271 | $1,923,394 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
This page
|
296,431 | $1,719,299 |
All Filings in XERS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,719,299 | 296,431 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,842,575 | 234,723 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,478,662 | 304,504 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,816,938 | 389,066 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,294,916 | 600,167 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $349,170 | 103,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $491,131 | 172,327 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $756,105 | 336,047 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $642,000 | 290,498 | Shares | Sole | 2024-05-15 | |
| 2023-06-30 | $67,596 | 25,800 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $32,000 | 12,500 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||